Phase II Study Of OSI-774 In Advanced Esophageal Cancer
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2013
At a glance
- Drugs Erlotinib (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 03 Jul 2007 Status changed from in progress to completed.
- 31 Aug 2005 New trial record.